Steven Hsu

Medicine & Life Sciences

1. Heart-Assist Devices 100%
2. Pulmonary Arterial Hypertension 63%
3. Heart Transplantation 46%
4. Heart Failure 44%
5. Pulmonary Hypertension 36%
6. Type 5 Cyclic Nucleotide Phosphodiesterases 32%
7. Systemic Scleroderma 30%
8. Heart 28%
9. Sildenafil Citrate 25%
10. Pressure 24%
11. Right Ventricular Function 23%
12. Hemodynamics 21%
13. Right Ventricular Dysfunction 19%
14. Exercise 19%
15. Arrhythmogenic Right Ventricular Dysplasia 18%
16. Transplants 17%
17. Ventricular Pressure 14%
18. Mortality 13%
19. Cardiomegaly 13%
20. Muscle Cells 12%
21. Cyclic GMP-Dependent Protein Kinases 12%
22. Lung 11%
23. Transplantation 11%
24. Heart Diseases 11%
25. Survival 11%
26. Noninvasive Ventilation 10%
27. Natriuretic Peptides 10%
28. Hypertrophy 10%
29. Stroke Volume 10%
30. Registries 10%
31. ITI-214 10%
32. Cardiogenic Shock 10%
33. Echocardiography 9%
34. Hospitalization 9%
35. Phosphodiesterase 5 Inhibitors 9%
36. Artificial Respiration 8%
37. Blood Pressure 8%
38. Sarcomeres 8%
39. Cardiac Catheterization 8%
40. Nitric Oxide Synthase 8%
41. Equipment and Supplies 8%
42. Calcineurin 8%
43. Heart Ventricles 8%
44. Familial Primary Pulmonary Hypertension 8%
45. Constriction 8%
46. Allografts 7%
47. Brain Natriuretic Peptide 7%
48. Dilatation 7%
49. Cardiac Output 7%
50. Calcium 7%